Pfizer

From Wikipedia, the free encyclopedia

Jump to navigationJump to search
For the COVID-19 vaccine, see Pfizer–BioNTech COVID-19 vaccine. For other uses, see Pfizer
(disambiguation).
Coordinates: 41.3343429°N 72.06795°W

Pfizer Inc.

Logo since January 5, 2021

Pfizer headquarters on 42nd Street in Midtown Manhattan

Type Public

Traded as • NYSE: PFE

• S&P 100 component
• S&P 500 component
• Russell 1000 Index component

Industry Pharmaceutical

Founded 1849; 172 years ago in New York City

Founders • Charles Pfizer

• Charles F. Erhart

Headquarters New York City, New York

Area served Worldwide

Key people Albert Bourla, Chairman & CEO

Frank A. D’Amelio, CFO
Mikael Dolsten, CSO
Lidia Fonseca, CTO
Scott Gottlieb, Director
Helen Hobbs, Director
Susan Hockfield, Director
Dan Littman, Director
Shantanu Narayen, Director
Suzanne Nora Johnson, Director
James Quincey, Director
Jim Smith, Director

Products • Pharmaceuticals
• vaccines

Revenue $41.908 billion (2020)

Operating income $8.16 billion (2020)

Net income $9.615 billion (2020)

Total assets $178.983 billion (2020)

Total equity $65.495 billion (2020)

Number of 78,500 of which 29,400 are in the United

employees States (2020)

Website www.pfizer.com

Footnotes / references
[1]
The headquarters of Pfizer Japan in Tokyo
Pfizer Inc. (/ˈfaɪzər/ FY-zər)[2] is an American multinational pharmaceutical corporation
headquartered on 42nd Street in Manhattan, New York City. The name of the company
commemorates its co-founder, Charles Pfizer (1824-1906).
Pfizer develops and
produces medicines and vaccines for immunology, oncology, cardiology, endocrinology,
and neurology. The company has several blockbuster drugs or products that each generate more
than US$1 billion in annual revenues.[1]
In 2020, 52% of the company's revenues came from the United States, 6% came from each of China
and Japan, and 36% came from other countries.[1]
The company ranks 64th on the Fortune 500[3] and 49th on the Forbes Global 2000.[4]
Pfizer was a component of the Dow Jones Industrial Average stock market index from 2004 to
August 2020.[5][6][7][8]

Contents

• 1Major products
• 2History
o 2.11849–1950: Early history
o 2.21950–1980: Pivot to pharmaceutical research and global expansion
o 2.31980–2000: Development of Viagra, Zoloft, and Lipitor
o 2.42000–2010: Further expansion
▪ 2.4.1Acquisitions and mergers
o 2.52010–2020: Further discoveries and acquisitions
o 2.62020s: COVID-19 vaccine and other initiatives
▪ 2.6.1COVID-19 pandemic and vaccine development
▪ 2.6.1.1Initial development and testing
▪ 2.6.1.2Efficacy results and authorization
▪ 2.6.1.3Manufacturing and distribution
▪ 2.6.1.4Controversy
▪ 2.6.2Other initiatives
o 2.7Acquisition history
• 3Legal issues
 o 3.1Aggressive pharmaceutical marketing
▪ 3.1.1Illegal marketing of gabapentin for off-label uses
▪ 3.1.2Illegal marketing of Bextra
▪ 3.1.3Termination of Peter Rost
▪ 3.1.4Illegal marketing of Rapamune
▪ 3.1.5Illegal marketing
o 3.2Removal of ads after unflattering article
o 3.3Quigley Company asbestos
o 3.4Shiley defective heart valves
o 3.5Firing of employee that filed suit
o 3.6Celebrex intellectual property
o 3.7Nigeria Trovafloxacin lawsuit
• 4Environmental record
• 5Political lobbying
• 6See also
• 7References
• 8External links